Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.
Kevin O'GallagherAnthony ShekDaniel M BeanRebecca BendayanAlexandros PapachristidisJames T H TeoRichard J B DobsonAjay M ShahRosita ZakeriPublished in: BMC cardiovascular disorders (2021)
In patients hospitalised with COVID-19, pre-existing established CVD appears to be a more important contributor to mortality than CV risk factors in the absence of CVD. CVD-related hazard may be mediated, in part, by new CV complications. Optimal care and vigilance for destabilised CVD are essential in this patient group. Trial registration n/a.
Keyphrases
- risk factors
- cardiovascular risk factors
- cardiovascular disease
- coronavirus disease
- sars cov
- end stage renal disease
- cardiovascular events
- healthcare
- chronic kidney disease
- ejection fraction
- newly diagnosed
- palliative care
- clinical trial
- metabolic syndrome
- type diabetes
- case report
- peritoneal dialysis
- study protocol
- quality improvement
- coronary artery disease
- respiratory syndrome coronavirus
- drug induced
- affordable care act
- double blind